Skip to main content
. Author manuscript; available in PMC: 2018 May 7.
Published in final edited form as: Hum Immunol. 2016 May 20;77(8):652–657. doi: 10.1016/j.humimm.2016.05.018

Table 1.

Descriptive and clinical information on research subjects.

Controls
(n = 6)
PTSD
(n = 7)
p
Age 39.0 ± 7.5 44.4 ± 9.6 NS
Males 5 (83.3%) 7 (100%) NS
Race NS
 Caucasian 5 (83.3%) 4 (57.1%)
 African American 0 (0.0%) 3 (42.9%)
 Hispanic 1 (16.7%) 0 (0.0%)
Combat exposure severity 9.67 ± 9.09 13.43 ± 5.71 NS
PTSD severity 11.7 ± 22.8 75.9 ± 13.3 <0.0005
HAM-D 4.0 ± 6.2 22.7 ± 10.6 <0.002

Combat exposure severity = CES total score; PTSD severity = CAPS total score. The p-values represent results of t-tests between groups except for the p-value for race, which is the result of Fisher’s exact test.